Mara Lorenzi

9.4k total citations · 2 hit papers
102 papers, 7.7k citations indexed

About

Mara Lorenzi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Ophthalmology. According to data from OpenAlex, Mara Lorenzi has authored 102 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 30 papers in Endocrinology, Diabetes and Metabolism and 27 papers in Ophthalmology. Recurrent topics in Mara Lorenzi's work include Retinal Diseases and Treatments (26 papers), Pancreatic function and diabetes (19 papers) and Advanced Glycation End Products research (12 papers). Mara Lorenzi is often cited by papers focused on Retinal Diseases and Treatments (26 papers), Pancreatic function and diabetes (19 papers) and Advanced Glycation End Products research (12 papers). Mara Lorenzi collaborates with scholars based in United States, Italy and Singapore. Mara Lorenzi's co-authors include Chiara Gerhardinger, Enrico Cagliero, Masakazu Mizutani, Timothy S. Kern, John E. Gerich, Peter H. Forsham, Veronica Asnaghi, Sumon Roy, John H. Karam and Giulio R. Romeo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mara Lorenzi

99 papers receiving 7.2k citations

Hit Papers

Accelerated death of retinal microvascular cells ... 1974 2026 1991 2008 1996 1974 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mara Lorenzi United States 44 2.8k 2.5k 2.0k 1.5k 1.3k 102 7.7k
Hans‐Peter Hammes Germany 44 4.6k 1.7× 2.9k 1.2× 1.9k 1.0× 2.4k 1.6× 901 0.7× 179 11.7k
Ronald L. Engerman United States 39 1.5k 0.6× 2.0k 0.8× 910 0.5× 1.4k 0.9× 390 0.3× 79 4.7k
Timothy S. Kern United States 33 1.8k 0.7× 2.0k 0.8× 704 0.4× 1.6k 1.1× 293 0.2× 64 4.9k
Jennifer L. Wilkinson‐Berka Australia 50 2.4k 0.9× 2.2k 0.9× 1.1k 0.6× 659 0.4× 441 0.4× 131 6.4k
Edward P. Feener United States 43 2.8k 1.0× 940 0.4× 1.1k 0.6× 400 0.3× 697 0.6× 94 6.7k
Renu A. Kowluru United States 48 3.0k 1.1× 2.1k 0.8× 496 0.3× 1.2k 0.8× 531 0.4× 113 5.5k
Timothy S. Kern United States 56 5.3k 1.9× 6.8k 2.8× 970 0.5× 2.4k 1.5× 579 0.5× 148 12.0k
Azza B. El‐Remessy United States 43 2.2k 0.8× 1.6k 0.6× 429 0.2× 683 0.4× 374 0.3× 106 5.5k
Julia V. Busik United States 35 1.8k 0.6× 928 0.4× 362 0.2× 312 0.2× 435 0.3× 92 3.5k
Shali Chen Canada 37 2.4k 0.9× 671 0.3× 361 0.2× 508 0.3× 374 0.3× 84 4.5k

Countries citing papers authored by Mara Lorenzi

Since Specialization
Citations

This map shows the geographic impact of Mara Lorenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Lorenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Lorenzi more than expected).

Fields of papers citing papers by Mara Lorenzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Lorenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Lorenzi. The network helps show where Mara Lorenzi may publish in the future.

Co-authorship network of co-authors of Mara Lorenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Lorenzi. A scholar is included among the top collaborators of Mara Lorenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Lorenzi. Mara Lorenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Feke, Gilbert T., et al.. (2008). Abnormal Retinal Vascular Reactivity in Response to Posture Change in Well-Controlled Type 1 Diabetic Patients With No Retinopathy. 49(13). 3263–3263. 5 indexed citations
3.
Lorenzi, Mara. (2006). Mechanisms and strategies for prevention in diabetic retinopathy. Current Diabetes Reports. 6(2). 102–107. 6 indexed citations
4.
Kern, Timothy S., Jie Tang, Masakazu Mizutani, et al.. (2000). Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.. PubMed. 41(12). 3972–8. 225 indexed citations
5.
Podestà, F, Timothy P. Roth, F. Ferrara, Enrico Cagliero, & Mara Lorenzi. (1997). Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication. Diabetologia. 40(8). 879–886. 27 indexed citations
6.
Faria, José B. Lopes de, Driss Zoukhri, & Mara Lorenzi. (1997). Mesangial cell abnormalities in spontaneously hypertensive rats before the onset of hypertension. Kidney International. 52(2). 387–392. 13 indexed citations
7.
Roy, Sumon & Mara Lorenzi. (1996). Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats. Diabetologia. 39(6). 735–738. 47 indexed citations
8.
Baumgartner‐Parzer, Sabina, et al.. (1996). Failure of High Ambient Glucose to Affect Endothelin-1 Synthesis or Release by Cultured Human Endothelial Cells. Hormone and Metabolic Research. 28(11). 610–612. 3 indexed citations
9.
Roy, Sayon, Enrico Cagliero, & Mara Lorenzi. (1996). Fibronectin overexpression in retinal microvessels of patients with diabetes.. PubMed. 37(2). 258–66. 101 indexed citations
10.
Roy, Sayon, M Maiello, & Mara Lorenzi. (1994). Increased expression of basement membrane collagen in human diabetic retinopathy.. Journal of Clinical Investigation. 93(1). 438–442. 90 indexed citations
11.
Boeri, D, Enrico Cagliero, F Podestà, & Mara Lorenzi. (1994). Vascular wall von Willebrand factor in human diabetic retinopathy.. PubMed. 35(2). 600–7. 14 indexed citations
12.
Rao, LV, SI Rapaport, & Mara Lorenzi. (1988). Enhancement by human umbilical vein endothelial cells of factor Xa- catalyzed activation of factor VII. Blood. 71(3). 791–796. 33 indexed citations
13.
Lorenzi, Mara, et al.. (1986). Studies on the permeability of the blood-brain barrier in experimental diabetes. Diabetologia. 29(1). 58–62. 46 indexed citations
14.
Lorenzi, Mara & J H Karam. (1985). Human insulin in the treatment of insulin allergy.. PubMed. 143(3). 387–8. 1 indexed citations
15.
Lorenzi, Mara, et al.. (1985). Glucose Toxicity for Human Endothelial Cells in Culture: Delayed Replication, Disturbed Cell Cycle, and Accelerated Death. Diabetes. 34(7). 621–627. 260 indexed citations
16.
17.
Lorenzi, Mara, Nancy J.V. Bohannon, Eva Tsalikian, & John H. Karam. (1984). Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.. PubMed. 141(4). 467–71. 17 indexed citations
18.
Bohannon, Nancy V., Mara Lorenzi, Gerold M. Grodsky, & John H. Karam. (1982). Stimulatory Effects of Tolbutamide Infusion on Plasma Glucagon in Insulin-Dependent Diabetic Subjects*. The Journal of Clinical Endocrinology & Metabolism. 54(2). 459–462. 24 indexed citations
19.
Lorenzi, Mara, Eva Tsalikian, Nancy V. Bohannon, et al.. (1977). Differential Effects ofl-Dopa and Apomorphine on Glucagon Secretion in Man: Evidence Against Central Dopaminergic Stimulation of Glucagon. The Journal of Clinical Endocrinology & Metabolism. 45(6). 1154–1158. 13 indexed citations
20.
Gerich, John E., J H Karam, Mara Lorenzi, Mark Donowitz, & Philip Felig. (1976). DIABETES WITHOUT GLUCAGON. The Lancet. 307(7964). 855–856. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026